Turtle Cameron

CIK 00017583634 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001758363

Recent Transactions

50 trades

Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-01-09+528,000→ 528,000 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-01-02$30.47/sh−12,709→ 674,198 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-01-02$32.39/sh−100→ 671,907 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-01-02$31.79/sh−2,191→ 672,007 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2025-12-01$28.73/sh−10,995→ 690,912 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2025-12-01$29.83/sh−4,005→ 686,907 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2025-11-03$23.13/sh−28,155→ 718,752 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2025-11-03$23.66/sh−16,845→ 701,907 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2025-06-02+17,500→ 17,500 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2025-01-15+370,000→ 370,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Common Stock
2024-02-15$9.82/sh+400→ 746,907 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2024-02-01+277,750→ 277,750 total
Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2023-11-24+723,440→ 746,507 total
Conversion
Spyre Therapeutics, Inc.$SYRE
Series A Preferred Stock
2023-11-24−18,086→ 0 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2023-11-22+374,000→ 374,000 total
Disposition to Issuer
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-26−53,157→ 0 total
Disposition from Tender
Eidos Therapeutics, Inc.
Common Stock
2021-01-26−50,699→ 0 total
Disposition to Issuer
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-26−9,469→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-28−6,000→ 31,766 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-12-28$0.34/sh+6,000→ 26,068 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-12-28$69.94/sh−8,563→ 12,568 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-28−7,500→ 255,500 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-12-28$17.00/sh+7,500→ 20,068 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-28−6,000→ 56,042 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-12-28$0.16/sh+6,000→ 32,068 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-12-28$69.34/sh−10,937→ 21,131 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2020-12-15$13.20/sh+21,843→ 76,915 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-12-15$112.19/sh−11,445→ 54,114 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-12-15−4,451→ 9,469 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-12-15−21,843→ 53,157 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2020-12-15$17.00/sh+4,451→ 55,072 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-12-15$112.97/sh−3,493→ 50,621 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-12-15$110.29/sh−3,756→ 73,159 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-12-15$111.31/sh−7,600→ 65,559 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-25$47.23/sh−742→ 12,568 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-25$17.00/sh+742→ 13,310 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-11-25−742→ 263,000 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-11-24−4,258→ 263,742 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-24$17.00/sh+4,258→ 16,826 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-24$47.00/sh−4,258→ 12,568 total
Gift
Eidos Therapeutics, Inc.
Common Stock
2020-11-11−1,500→ 50,621 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-11-11$74.75/sh−9,497→ 53,029 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-11-11$73.56/sh−3,005→ 62,526 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-11-11$75.23/sh−908→ 52,121 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-11-05−2,500→ 268,000 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-05$42.05/sh−2,500→ 12,568 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-05$17.00/sh+2,500→ 15,068 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-11-02$71.42/sh−3,146→ 65,740 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-11-02−2,500→ 13,920 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-11-02−5,000→ 75,000 total

Companies

Recent Filings

Address

221 CRESCENT STREET, BUILDING 23, SUITE 105

WALTHAM, MA, 02453

View on SEC.gov